MedTrace Logo

Neuromodulation for Behavioral Changes in Neurological Disorders

NCT07718906 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-07-22

No results posted yet for this study

Summary

The purpose of this study is to see if a focused ultrasound neuromodulation can be safely and effectively used to treat symptoms of emotional dysregulation such as agitation, irritability and anxiety

Conditions

Interventions

DEVICE

Focused Ultrasound

Subjects will undergo a single focused ultrasound Neuromodulation of the target brain region

Sponsors & Collaborators

  • West Virginia University

    lead OTHER

Principal Investigators

  • Ali Rezai · WVU Rockefeller Neuroscience Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-25
Primary Completion
2027-12-30
Completion
2028-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07718906 on ClinicalTrials.gov